Clinical Trials Directory

Trials / Conditions / Cancer of Head and Neck

Cancer of Head and Neck

74 registered clinical trials studyying Cancer of Head and Neck4 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingDiscontinuation of Tobacco Dependence in Smoking Patients With Squamous Cell Carcinoma of the Head-neck Distri
NCT06995417
Azienda Ospedaliero-Universitaria Careggi
Not Yet RecruitingArtificial Intelligence-based Voice Assessment of Children and Adults Respiratory Conditions
NCT06630078
Fondazione Policlinico Universitario Agostino Gemelli IRCCSN/A
UnknownLung Ultrasound Score After ENT Cancer Surgery
NCT05482841
Centre Leon Berard
CompletedLymphoedema Among Persons With Head- and Neck Cancer
NCT05316974
Lund University
WithdrawnEfficacy of Ketamine Mouthwash in the Management of Oral and Pharyngeal Toxicity Associated With Head and Neck
NCT05331131
Northwell HealthPhase 2
CompletedThe Gut Microbiome As an Indicator of Readiness for Head & Neck Cancer Surgery
NCT05061316
University of Alabama at BirminghamN/A
CompletedRCT of Effects of Mindfulness-based Stress Reduction in Head and Neck Cancer
NCT04800419
Universiti Sains MalaysiaN/A
Active Not RecruitingA Comprehensive Approach to Head and Neck Cancer Prehabilitation
NCT04617678
Sanford HealthN/A
RecruitingInterest of Bilateral Basic Tongue Mucosectomy Assisted by Robot or Laser in Combination with Tonsillectomy in
NCT04767048
Centre Francois BaclessePhase 2
Active Not RecruitingOnco-primary Care Networking to Support TEAM-based Care
NCT04258813
Duke UniversityN/A
TerminatedEffects of Oral Cancer Treatments on Upper Esophageal Opening During Swallowing
NCT04658342
University of Wisconsin, Madison
CompletedTrial Evaluating Adapted Chemotherapy in Patients With Squamous Carcinoma
NCT04356170
Groupe Oncologie Radiotherapie Tete et CouPhase 2
CompletedHeavy Lifting Strength Training in Head and Neck Cancer Survivors
NCT04554667
University of AlbertaPhase 1
UnknownAssessment of the Prevalence of Sarcopenia by CT Scan in Patients Diagnosed With Head & Neck Cancer
NCT04804852
Weprom
Active Not RecruitingTempus Priority Study: A Pan-tumor Observational Study
NCT05179824
Tempus AI
CompletedPostoperative Pain, Why Still in Hospital and DAOH Following TORS for SCCUP & OSAS
NCT04189107
Rigshospitalet, DenmarkPhase 3
CompletedRadiogenomics in Aerodigestive Tract Cancers
NCT04314349
Buddhist Tzu Chi General Hospital
CompletedFocused Ultrasound (FUS) Mesencephalotomy for Head & Neck Cancer Pain
NCT03894553
Jeff Elias, MDN/A
CompletedTadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer
NCT03993353
University of California, San DiegoPhase 2
RecruitingA Multicenter Cancer Biospecimen Collection Study
NCT04510129
Cofactor Genomics, Inc.
UnknownTargeting Potassium Channels to Reprogram Glioblastoma Microenvironment: in Vitro and in Vivo Studies
NCT03954691
Neuromed IRCCS
CompletedSingle-arm Phase II Study of NDURE for Patients With HNC
NCT03821064
Medical University of South CarolinaN/A
UnknownThe PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor
NCT03896958
SpeciCare
UnknownHead and Neck Cancer in Children: A Retrospective Study
NCT02557048
Assiut University
TerminatedPerioperative Analgesia Using Gabapentin in Head and Neck Cancer Surgery
NCT03682367
University of California, DavisPhase 3
UnknownPalliative and Oncology Care Intervention: Symptom COACH
NCT03760471
Fox Chase Cancer CenterN/A
UnknownHypnosis and Meditation for Cancer Pain
NCT03558594
VA Puget Sound Health Care SystemN/A
CompletedForecasts Impact of the Pre-therapeutic TEP-TDM in the 18-FDG Restaging of Upper Aero-digestive Tract Cancers
NCT03841175
University Hospital, Brest
Active Not RecruitingChemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer
NCT03383094
Loren Mell, MDPhase 2
CompletedEffectiveness and Safety of Nivolumab in Participants That Have Head and Neck Cancer That Has Come Back or Has
NCT03569436
Bristol-Myers Squibb
TerminatedStudy Comparing Pembrolizumab With Methotrexate in Elderly, Frail or Cisplatin-ineligible Patients With Head a
NCT03193931
AIO-Studien-gGmbHPhase 2
CompletedPrognostic Value of 18FDG PET/CT Textural Indices in HNSCC
NCT03378193
University Hospital, Brest
CompletedWearable Sensor for Biometrics During Locoregional Therapy for Head and Neck Cancer
NCT03574870
University of Texas Southwestern Medical CenterN/A
CompletedBrain Stimulation For Cancer Smokers
NCT03419741
Medical University of South CarolinaN/A
CompletedNurse-led Exercise Improves Shoulder Pain, Shoulder Disability, and Quality of Life in Head and Neck Cancer
NCT05269342
YU LONG HONGN/A
CompletedTrial To Test Safety And Efficacy Of Vaccination For Incurable HPV 16-Related Oropharyngeal, Cervical And Anal
NCT02865135
Dana-Farber Cancer InstitutePhase 1 / Phase 2
CompletedImproving Quality of Life Through the Routine Use of the Patient Concerns Inventory for Head and Neck Cancer P
NCT03086629
Liverpool University Hospitals NHS Foundation TrustN/A
TerminatedEvaluation of an Active Swallowing Rehabilitation on Quality of Life of Patients Treated by Radiotherapy for H
NCT02892487
Rennes University HospitalN/A
CompletedStudy to Compare the Effect of Two Different Types of Humidifier on the Endotracheal Tube Patency
NCT02780765
Tata Memorial HospitalN/A
CompletedEvaluation of Appeal and Impact of E-Cigarettes Among Chronic Smokers With Smoking-Related Cancers
NCT02648178
Dartmouth-Hitchcock Medical CenterN/A
CompletedSwallowing Rehabilitation in Patients With Head and Neck Cancer Receiving Radiotherapy
NCT02900911
Parc de Salut MarN/A
CompletedNab-Paclitaxel and Cisplatin or Nab-paclitaxel as Induction Therapy for Locally Advanced Squamous Cell Carcino
NCT02573493
Washington University School of MedicinePhase 2
UnknownBig Data and Models for Personalized Head and Neck Cancer Decision Support (BD2Decide)
NCT02832102
Azienda Ospedaliero-Universitaria di Parma
CompletedSafety and Tolerability Study of AlloVax(TM) in Patients With Metastatic or Recurrent Cancer of the Head and N
NCT01998542
Mirror Biologics, Inc.Phase 2
CompletedA Study Evaluating Safety, Pharmacokinetics, and Therapeutic Activity of RO6874281 as a Single Agent (Part A)
NCT02627274
Hoffmann-La RochePhase 1
CompletedTertiary Prevention of Head and Neck Cancer With a Dietary Intervention
NCT02869399
Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoN/A
CompletedImmunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma
NCT02296684
Washington University School of MedicinePhase 2
CompletedMulti-Site Pathological Images-Guided ViT for Oral Squamous Cell Carcinoma Recurrence Prediction
NCT06638762
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
TerminatedPilot Study of Metformin in HNSCC to Investigate the Effects of MF, Tumor Genotype and MF-genotype Interaction
NCT02402348
West Virginia UniversityEARLY_Phase 1
CompletedPain Control Using Neuromodulation in Patients Undergoing Definitive Chemoradiotherapy for Head and Neck Cance
NCT02366611
University of MichiganN/A
CompletedDe-Intensification Radiotherapy Postoperative Head Neck
NCT02528955
University of Erlangen-Nürnberg Medical SchoolPhase 2
CompletedQuick Diagnostic Program for Head and Neck Cancer
NCT02030509
Corporacion Parc Tauli
WithdrawnA Phase II Trial of Proton Pump Inhibitors With Chemotherapy in Patients With Metastatic Head and Neck Cancer
NCT02013453
University of Michigan Rogel Cancer CenterPhase 2
CompletedSoy Isoflavone in Combination With Radiation Therapy and Cisplatin in SCC of the Head and Neck
NCT02075112
Emory UniversityPhase 1
CompletedHyperbaric Oxygen and Its Effect on Radiation Induced Long Term Side Effects
NCT02450305
State University of New York - Upstate Medical University
CompletedComparison of Percutaneous Image-guided Gastrostomies
NCT02053428
University Health Network, TorontoN/A
CompletedValidation of High-resolution PET/CT for the Pretherapeutic Lymphnode Staging of Head/Neck Cancer
NCT02372890
Insel Gruppe AG, University Hospital Bern
CompletedEfficacy of Novel Edible Gel-based Artificial Saliva in Cancer Patients
NCT01885065
Dental Innovation Foundation Under Royal PatronageN/A
CompletedExercise and Nutrition for Head and Neck Cancer Patients
NCT01681654
University of CalgaryN/A
CompletedSafety Study of Attenuated Vaccinia Virus (GL-ONC1)With Combination Therapy in Head & Neck Cancer
NCT01584284
Genelux CorporationPhase 1
UnknownClinic Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics
NCT02441972
Wuxi No. 4 People's HospitalPhase 1
CompletedTreatment of Pain in Head-and-Neck Cancer Patients: is Methadone More Effective?
NCT01317589
Maastricht University Medical CenterPhase 4
CompletedA Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Car
NCT01059643
Eli Lilly and CompanyPhase 2
TerminatedTo Determine Safe and Effective Dose of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Partic
NCT01284348
Merck Sharp & Dohme LLCPhase 2
CompletedPhase I Chemoprevention Trial With Green Tea Polyphenon E & Erlotinib in Patients With Premalignant Lesions of
NCT01116336
Emory UniversityPhase 1
CompletedAdaptive Radiation Therapy for Head & Neck Cancer Patients
NCT01853670
Beth Israel Medical CenterN/A
CompletedPrognostic Evaluation of 18fmiso Pet-ct in Head and Neck Cancer
NCT01235052
University Hospital, BordeauxN/A
CompletedTrial of Postoperative Radiation, Cisplatin, and Panitumumab in Locally Advanced Head and Neck Cancer
NCT00798655
Robert FerrisPhase 2
CompletedEvaluation of Cetuximab (ERBITUX) and Concurrent Carboplatin, Paclitaxel & Radiotherapy in the Management of P
NCT00343083
University of Maryland, BaltimorePhase 2
TerminatedAssessment of Early Genetic Changes in Smokers
NCT00200408
Montefiore Medical Center
CompletedThe IRESSA Novel Head and Neck Chemotherapy Evaluation Study
NCT00255476
AstraZenecaPhase 2
CompletedIRESSA in Combination With Cisplatin & Radiotherapy in Patients With Advanced Head & Neck Carcinoma
NCT00242749
AstraZenecaPhase 2
CompletedCisplatin and Docetaxel Plus Docetaxel and Radiotherapy With Amifostine for Squamous Cell Carcinoma of the Hea
NCT00318890
University of Alabama at BirminghamPhase 1 / Phase 2
CompletedA Phase IB Study Of Oral SCH 66336 Preoperatively In Patients With Head And Neck Squamous Cell Cancer
NCT00038584
M.D. Anderson Cancer CenterPhase 1